Literature DB >> 20542094

Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex.

S M Eggan1, D S Melchitzky, S R Sesack, K N Fish, D A Lewis.   

Abstract

Exposure to cannabis impairs cognitive functions reliant on the circuitry of the dorsolateral prefrontal cortex (DLPFC) and increases the risk of schizophrenia. The actions of cannabis are mediated via the brain cannabinoid 1 receptor (CB1R), which in rodents is heavily localized to the axon terminals of cortical GABA basket neurons that contain cholecystokinin (CCK). Differences in the laminar distribution of CB1R-immunoreactive (IR) axons have been reported between rodent and monkey neocortex, suggesting that the cell type(s) containing CB1Rs, and the synaptic targets of CB1R-IR axon terminals, may differ across species; however, neither the relationship of CB1Rs to CCK-containing interneurons, nor the postsynaptic targets of CB1R and CCK axon terminals, have been examined in primate DLPFC. Consequently, we compared the distribution patterns of CB1R- and CCK-IR structures, determined the proportions of CB1R and CCK neurons that were dual-labeled, and identified the synaptic types and postsynaptic targets of CB1R- and CCK-IR axon terminals in macaque monkey DLPFC. By light microscopy, CB1R- and CCK-IR axons exhibited a similar laminar distribution, with their greatest densities in layer 4. Dual-label fluorescence experiments demonstrated that 91% of CB1R-IR neurons were immunopositive for CCK, whereas only 51% of CCK-IR neurons were immunopositive for CB1R. By electron microscopy, all synapses formed by CB1R-IR axon terminals were symmetric, whereas CCK-IR axon terminals formed both symmetric (88%) and asymmetric (12%) synapses. The primary postsynaptic target of both CB1R- and CCK-IR axon terminals forming symmetric synapses was dendritic shafts (81-88%), with the remainder targeting cell bodies or dendritic spines. Thus, despite species differences in laminar distribution, CB1Rs are principally localized to CCK basket neuron axons in both rodent neocortex and monkey DLPFC. These axons target the perisomatic region of pyramidal neurons, providing a potential anatomical substrate for the impaired function of the DLPFC associated with cannabis use and schizophrenia. (c) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20542094      PMCID: PMC3030191          DOI: 10.1016/j.neuroscience.2010.06.011

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  63 in total

1.  Cannabinoids reveal importance of spike timing coordination in hippocampal function.

Authors:  David Robbe; Sean M Montgomery; Alexander Thome; Pavel E Rueda-Orozco; Bruce L McNaughton; György Buzsaki
Journal:  Nat Neurosci       Date:  2006-11-19       Impact factor: 24.884

2.  Asynchronous GABA release generates long-lasting inhibition at a hippocampal interneuron-principal neuron synapse.

Authors:  Stefan Hefft; Peter Jonas
Journal:  Nat Neurosci       Date:  2005-09-11       Impact factor: 24.884

3.  An open letter to our readers on the use of antibodies.

Authors:  Clifford B Saper
Journal:  J Comp Neurol       Date:  2005-12-26       Impact factor: 3.215

4.  Complementary roles of cholecystokinin- and parvalbumin-expressing GABAergic neurons in hippocampal network oscillations.

Authors:  Thomas Klausberger; Laszlo F Marton; Joseph O'Neill; Jojanneke H J Huck; Yannis Dalezios; Pablo Fuentealba; Wai Yee Suen; Edit Papp; Takeshi Kaneko; Masahiko Watanabe; Jozsef Csicsvari; Peter Somogyi
Journal:  J Neurosci       Date:  2005-10-19       Impact factor: 6.167

5.  Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types.

Authors:  Agnes L Bodor; István Katona; Gábor Nyíri; Ken Mackie; Catherine Ledent; Norbert Hájos; Tamás F Freund
Journal:  J Neurosci       Date:  2005-07-20       Impact factor: 6.167

6.  Molecular composition of the endocannabinoid system at glutamatergic synapses.

Authors:  István Katona; Gabriella M Urbán; Matthew Wallace; Catherine Ledent; Kwang-Mook Jung; Daniele Piomelli; Ken Mackie; Tamás F Freund
Journal:  J Neurosci       Date:  2006-05-24       Impact factor: 6.167

7.  Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells.

Authors:  Lindsey L Glickfeld; Massimo Scanziani
Journal:  Nat Neurosci       Date:  2006-04-30       Impact factor: 24.884

Review 8.  Cortical inhibitory neurons and schizophrenia.

Authors:  David A Lewis; Takanori Hashimoto; David W Volk
Journal:  Nat Rev Neurosci       Date:  2005-04       Impact factor: 34.870

9.  The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum.

Authors:  Yoshinobu Kawamura; Masahiro Fukaya; Takashi Maejima; Takayuki Yoshida; Eriko Miura; Masahiko Watanabe; Takako Ohno-Shosaku; Masanobu Kano
Journal:  J Neurosci       Date:  2006-03-15       Impact factor: 6.167

10.  Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates others.

Authors:  Miranda A Karson; Kevin C Whittington; Bradley E Alger
Journal:  Neuropharmacology       Date:  2007-07-01       Impact factor: 5.250

View more
  47 in total

1.  The effect of chronic cannabinoids on broadband EEG neural oscillations in humans.

Authors:  Patrick D Skosnik; Deepak C D'Souza; Adam B Steinmetz; Chad R Edwards; Jennifer M Vollmer; William P Hetrick; Brian F O'Donnell
Journal:  Neuropsychopharmacology       Date:  2012-06-20       Impact factor: 7.853

Review 2.  Functional Relevance of Endocannabinoid-Dependent Synaptic Plasticity in the Central Nervous System.

Authors:  Shana M Augustin; David M Lovinger
Journal:  ACS Chem Neurosci       Date:  2018-02-19       Impact factor: 4.418

3.  Functional properties of GABA synaptic inputs onto GABA neurons in monkey prefrontal cortex.

Authors:  Diana C Rotaru; Cameron Olezene; Takeaki Miyamae; Nadezhda V Povysheva; Aleksey V Zaitsev; David A Lewis; Guillermo Gonzalez-Burgos
Journal:  J Neurophysiol       Date:  2014-12-24       Impact factor: 2.714

4.  GABA Deficits Enhance the Psychotomimetic Effects of Δ9-THC.

Authors:  Rajiv Radhakrishnan; Patrick D Skosnik; Jose Cortes-Briones; R Andrew Sewell; Michelle Carbuto; Ashley Schnakenberg; John Cahill; Fred Bois; Handan Gunduz-Bruce; Brian Pittman; Mohini Ranganathan; Deepak Cyril D'Souza
Journal:  Neuropsychopharmacology       Date:  2015-03-02       Impact factor: 7.853

5.  Disrupted gamma-band neural oscillations during coherent motion perception in heavy cannabis users.

Authors:  Patrick D Skosnik; Giri P Krishnan; Deepak C D'Souza; William P Hetrick; Brian F O'Donnell
Journal:  Neuropsychopharmacology       Date:  2014-07-03       Impact factor: 7.853

6.  Resting state functional magnetic resonance imaging reveals distinct brain activity in heavy cannabis users - a multi-voxel pattern analysis.

Authors:  H Cheng; P D Skosnik; B J Pruce; M S Brumbaugh; J M Vollmer; D J Fridberg; B F O'Donnell; W P Hetrick; S D Newman
Journal:  J Psychopharmacol       Date:  2014-09-18       Impact factor: 4.153

Review 7.  Neurodevelopment, GABA system dysfunction, and schizophrenia.

Authors:  Martin J Schmidt; Karoly Mirnics
Journal:  Neuropsychopharmacology       Date:  2014-04-24       Impact factor: 7.853

8.  Impact of Cannabis Use on the Development of Psychotic Disorders.

Authors:  Samuel T Wilkinson; Rajiv Radhakrishnan; Deepak Cyril D'Souza
Journal:  Curr Addict Rep       Date:  2014-06-01

Review 9.  Layer 3 Excitatory and Inhibitory Circuitry in the Prefrontal Cortex: Developmental Trajectories and Alterations in Schizophrenia.

Authors:  Gil D Hoftman; Dibyadeep Datta; David A Lewis
Journal:  Biol Psychiatry       Date:  2016-06-04       Impact factor: 13.382

10.  The role of cannabinoid 1 receptor expressing interneurons in behavior.

Authors:  Jacquelyn A Brown; Szatmár Horváth; Krassimira A Garbett; Martin J Schmidt; Monika Everheart; Levente Gellért; Philip Ebert; Károly Mirnics
Journal:  Neurobiol Dis       Date:  2013-11-13       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.